Literature DB >> 9525739

Bcl-X is the major pleiotropic anti-apoptotic gene activated by retroviral insertion mutagenesis in an IL-3 dependent bone marrow derived cell line.

J Thomas1, Y Leverrier, J Marvel.   

Abstract

In order to identify genes capable of inhibiting apoptosis induced by different pathways, without inducing proliferation we have performed retroviral insertion mutagenesis in the IL-3 dependent bone marrow derived Baf-3 cell line. Out of 200 mutants obtained in three separate mutagenesis experiments, four mutants were resistant to multiple apoptosis inducing pathways (including growth factor starvation, staurosporine, etoposide and cyclosporin A) and did not proliferate in the absence of IL-3. These four mutants overexpress the bcl-X gene following a retroviral insertion 5' of the translation initiation site. These results indicate that the bcl-X gene is a major pleiotropic anti-apoptotic gene in Baf-3 cells. They also suggest that the Bcl-2 family of genes might be the only one capable of inhibiting apoptosis induced by multiple pathways without inducing cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525739     DOI: 10.1038/sj.onc.1201672

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Modulation of gene expression in endothelial cells by hyperlipaemic postprandial serum from healthy volunteers.

Authors:  Nicolas Dejeans; Jeanette A M Maier; Igor Tauveron; Dragan Milenkovic; Andrzej Mazur
Journal:  Genes Nutr       Date:  2010-02-02       Impact factor: 5.523

2.  Insertional gene activation by lentiviral and gammaretroviral vectors.

Authors:  Marieke Bokhoven; Sam L Stephen; Sean Knight; Evelien F Gevers; Iain C Robinson; Yasuhiro Takeuchi; Mary K Collins
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

3.  Key genes and drug delivery systems to improve the efficiency of chemotherapy.

Authors:  Zally Torres-Martinez; Yamixa Delgado; Yancy Ferrer-Acosta; Ivette J Suarez-Arroyo; Freisa M Joaquín-Ovalle; Louis J Delinois; Kai Griebenow
Journal:  Cancer Drug Resist       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.